Navigation Links
DavosLife: Vitamin E Tocotrienol Shows Increased Cancer Cell Apoptosis Without Toxicity in Phase 1 Pancreatic Cancer Trial
Date:5/30/2011

SINGAPORE, May 30, 2011 /PRNewswire-Asia/ -- Davos Life Science (DavosLife) has today announced preliminary results of a phase I clinical trial of its Natural e3 delta-tocotrienol (Natural e3) in patients with resectable pancreatic cancer. Tocotrienols are highly potent members of the Vitamin E family that have been found by researchers to inhibit the growth and survival of various types of cancer cells. This clinical trial revealed that Natural e3 was able to increase apoptosis (cell death) in pancreatic cancer tumours, with no toxicity. The study was carried out by researchers at The H. Lee Moffitt Cancer Center & Research Institute in Florida, United States, and supported by DavosLife and by the U.S. National Institute of Health. This data was presented by the Moffitt Cancer Center at the recent American Association for Cancer Research (AACR) Annual Meeting.

For a period of 2 weeks prior to surgery, 12 subjects received Natural e3, with 3 subjects at each dose level of 200 mg, 400 mg, 600 mg and 800 mg per day. This oral treatment occurred pre-surgery to examine the effect of Natural e3 on the resected pancreatic cancer tumour. To assess for toxicity, blood samples were collected pre-dose on day 1, day 8, on the day of the patients' surgery and 3-6 weeks post-surgery. This trial occurred between October 2009 and August 2010.

The Moffitt Cancer Center researchers, led by Dr Mokenge Malafa, found no adverse drug-related events in the patients and no change in the rate of post-operative complications at doses up to 800 mg per day. They also found that giving patients daily doses of Natural e3 greater than 200 mg increased apoptosis in the pancreatic tumours as well as increased expression of p27, an important kinase inhibitor involved in the regulation of the cell cycle. Reduced levels of p27 have been found in some types of cancers.

"Pancreatic cancer is a highly fatal form of cancer with average 5 year survival rates at less than 10% from the time of discovery. We at The Moffitt Cancer Centre are researching into novel but safe compounds that could potentially help cancer patients. We are very pleased by the good biomarker activity and tolerability profile of Natural e3 found so far in our pancreatic cancer patients. We are moving ahead with the Phase I dose escalation trial with the next dose level of 1600mg per day already in progress," said Dr Malafa, Head of Pancreatic Oncology, at The Moffitt Cancer Center. Two phase 1 trials of Natural e3 in healthy subjects have also been initiated at the Moffitt Cancer Center.

"We are pleased to be supporting Moffitt's early Phase clinical trials of Natural e3 for cancer prevention and treatment. DavosLife is supplying all of the Natural e3 as well as part funding for the trials. Tocotrienols have been shown by various researchers to have good bio-activity in a range of human diseases. This is part of our efforts to advance the research into tocotrienols into new areas," said Mr Arthur Ling, CEO of DavosLife.

About Natural e3

Natural e3, the brand name for DavosLife tocotrienols, is extracted from GMO-free palm fruits from its parent company's plantations, using state-of-the-art technology to achieve the world's highest purity of up to 97% purity. Natural e3 has achieved GRAS (Generally Regarded As Safe) status, which is a food safety standard reviewed and approved by the U.S. Food and Drug Administration (FDA).

About DavosLife

DavosLife was established in 2004, as the world's largest tocotrienol manufacturer and research company. We conduct as well as support cutting edge research into the use of natural tocotrienols to prevent or treat common diseases such as cancers, metabolic syndrome and heart disease, and for skin care applications. DavosLife tocotrienols are sold to leading international nutraceutical and cosmeceutical finished product manufacturers under the brand name, Natural e3. For its commitment in advancing tocotrienol research, DavosLife is a distinguished recipient of the 2010 Asia Pacific Frost & Sullivan Excellence Award in the Vitamin E Market. For more information on the benefits and applications of Natural e3, please visit www.davoslife.com

About Moffitt Cancer Center

Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt's excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer. Moffitt's sole mission is to contribute to the prevention and cure of cancer.


'/>"/>
SOURCE Davos Life Science Pte Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
2. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
3. Scientists Reveal Roadmap to Brain Health That Can Be Passed Down to Future Generations: Exercise, Omega-3, Folic Acid, Vitamin B6, and Vitamin B12
4. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
5. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
6. Evidence Lacking in Multivitamin Study of Womens Risk of Cancer, Heart Disease or Death, Says Natural Products Association
7. Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss
8. Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
9. Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
10. July 2009 Mayo Clinic Womens HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
11. VitaminSpice Appoints Dr. Richard F. Seelig as Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Research and Markets has ... lymphocytic Leukemia Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Lymphocytic Leukemia epidemiology, Acute Lymphocytic Leukemia ...
(Date:5/3/2016)... from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and increase market presence. ... ... ... ... Sino-German High-Tech ...
(Date:5/3/2016)...  While you may be familiar with watching a film or TV show in high definition, ... 8MP in the Medical Industry.  Ampronix  is a renowned authorized reseller of the medical industry,s ... - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
Breaking Medicine Technology:
(Date:5/5/2016)... San Rafael, CA (PRWEB) , ... May 05, 2016 , ... ... Coach of the Year, Derek Pittman, along with his university coaching staff. Together they ... and girls, with separate sessions run for youth players ages 5-13, and high school ...
(Date:5/5/2016)... ... 05, 2016 , ... Chronic stress can have a silent, yet dangerous, impact ... immune system and increase inflammation, both of which raise the risk of heart attack ... disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also can lead to other ...
(Date:5/5/2016)... ... , ... With May flowers, summer is just around the corner. Summer means a lot of ... and the ability to play all day and night. Parents often lament the coming of ... tykes themselves. Summer also means trips to the beach, backyard cookouts, fireworks on the Fourth ...
(Date:5/5/2016)... ... May 05, 2016 , ... MAP Health ... announced today that Enlightened Solutions has joined the Premier Outcomes-Driven Provider Network. By ... continuum for their patients being treated for substance use. , Enlightened Solutions was ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... In the ... easy to forget the most important arrangement — planning a safe way of getting ... and popular tequila drinks. Unfortunately, these celebrations often lead to drunk drivers on the ...
Breaking Medicine News(10 mins):